NCT06422702View on ClinicalTrials.gov

The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 22, 2024

Study Completion Date

April 22, 2025

Conditions
Pathologically Confirmed Differentiated Thyroid CarcinomaAll Patients Are in the Initial Treatment PhaseNormal Cognitive and Communicative Abilities, Capable of Reading and Understanding Questionnaires in ChineseAbility to Use a SmartphoneVoluntary Participation in the Study and Signed Informed Consent
Interventions
OTHER

Psychosomatic Symptoms Intervention

Psychosomatic symptoms included intervention of negative psychological symptoms and intervention of physical discomfort symptoms.

OTHER

Extended supportive care

The control group implemented continuity of supportive care based on primary care

Trial Locations (1)

150000

Harbin Medical University, Harbin

All Listed Sponsors
lead

Harbin Medical University

OTHER